Results 151 to 160 of about 1,044,683 (223)

Albumin-bound paclitaxel and cisplatin with radiotherapy in locally advanced oesophageal squamous cell carcinoma: a single-arm, phase II trial. [PDF]

BMC Cancer
Yang S, Jiang H, Zhong L, Makelike K, Chen B, Xi M, Li Q, Hu Y, Meng F, Zhu Y.   +9 more
europepmc   +1 more source

Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel Compared to Docetaxel Plus Nedaplatin as Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis. [PDF]

Cancer Manag Res
Sun QQ, Chen J, Ye ZM, Hua YH, Liu LY, Liu T.   +5 more
europepmc   +1 more source

Neoadjuvant sintilimab, albumin-bound paclitaxel, and carboplatin for locally advanced, resectable esophageal squamous cell carcinoma: clinical study and mechanistic exploration. [PDF]

NPJ Precis Oncol
Wu H, Jiang Q, Li X, Ye P, Rusidanmu A, Li N, Teng X, Wang Q, Chen Y, Huang D, Han Y, Wang B, Yu W, Tao J, Ruan J, Jiang H.   +15 more
europepmc   +1 more source

Efficacy and Safety of Different Sequences for mFOLFIRINOX (or SOXIRI) and Gemcitabine Plus Albumin-Bound Paclitaxel in Unresectable Pancreatic Cancer. [PDF]

Immunotargets Ther
Huang S, Huang L, Zhang D, Jiang Q, Wang F, Guo G.   +5 more
europepmc   +1 more source

A case report: Achieving complete response in synchronous primary lung and tongue squamous cell carcinomas through the integration of albumin-bound paclitaxel, cisplatin, and tislelizumab. [PDF]

Hum Vaccin Immunother
Huang X, Ma Y, Wang H, Song S, Li T, Zhang C, Hou H.   +6 more
europepmc   +1 more source

Complete remission of recurrent human papillomavirus-associated cervical cancer managed with camrelizumab and nanoparticle albumin-bound paclitaxel as second-line treatment: a case report. [PDF]

Front Immunol
Sun L, Lang J, Wu X, Shi D, Sang J, Xiong Z.   +5 more
europepmc   +1 more source

Effects of albumin-bound paclitaxel combined with Sophora subprostrate polysaccharide on inflammatory factors and immune function in breast cancer rats. [PDF]

Discov Oncol
Ding C, Li Z, Zheng Y, Li K, Yu W, Kong L, Zhang Z.   +6 more
europepmc   +1 more source

Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis. [PDF]

Front Pharmacol
Duan Y, Wang Y, Lu S, Zeng M, Liu L, Dai Q, Yin R.   +6 more
europepmc   +1 more source

Efficacy and safety of fruquintinib combined with albumin-bound paclitaxel as second-line therapy for advanced gastric cancer following failure of PD-1 inhibitor-containing treatment (TACTIC GC-01): A phase II single-arm study. [PDF]

Int J Cancer
Ma X, Ou K, Liu X, Cao B, Yang W, Lu J, Zhang L, Wang Q, Gao L, Jiang Z, Sun Y, Yang L.   +11 more
europepmc   +1 more source

Albumin-bound paclitaxel combined with lobaplatin using different administration methods in the treatment of cervical cancer: Study on the efficacy and its effect on immune function and inflammatory response. [PDF]

Pak J Med Sci
Li R, Song R, Jiao Y, Liu D, Zhang L.
europepmc   +1 more source